Literature DB >> 19681947

Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease.

J M A Daniels1, C S de Graaff, F Vlaspolder, D Snijders, H M Jansen, W G Boersma.   

Abstract

Sputum colour is regarded as a good marker of bacterial involvement in acute exacerbations of chronic obstructive pulmonary disease (COPD) and guides many physicians in deciding on antibiotic treatment. Although most doctors rely on the sputum colour that is reported by patients, it can also be assessed using a validated colour chart. In this study, reported sputum colour and assessed sputum colour were compared as markers of the presence of bacteria, bacterial load, and systemic inflammation. Data on 257 exacerbations in 216 patients hospitalized with an acute exacerbation were analysed (mean age, 72 years; mean forced expiratory volume in 1 s, 44.8% + or - 17.8% (+ or - standard deviation)). Sputum colour was reported by the patients and assessed at the laboratory with a colour chart. Subsequently, quantitative sputum cultures were performed. C-reactive protein was measured as a marker of systemic inflammation. A sputum sample was obtained in 216 exacerbations (84%), of which 177 (82%) were representative. A pathogen was identified in 155 patients (60%). Assessed sputum colour was a better marker of the presence of bacteria (OR 9.8; 95% CI 4.7-20.4; p <0.001) than reported sputum colour (OR 1.7; 95% CI 1.0-3.0; p 0.041). The sensitivity and specificity were 73% and 39% for reported sputum colour, and 90% and 52% for assessed sputum colour. Assessed sputum colour was clearly related to sputum bacterial load and C-reactive protein levels, whereas reported sputum colour was not. It is concluded that sputum colour reported by patients is an unreliable marker of the presence of bacteria in acute exacerbations of COPD. Assessed sputum colour is clearly superior and is also related to bacterial load and systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19681947     DOI: 10.1111/j.1469-0691.2009.02892.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Pharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients.

Authors:  Deepali Dixit; Mary Barna Bridgeman; Rani Patel Madduri; Samir T Kumar; Michael J Cawley
Journal:  P T       Date:  2016-11

2.  Diagnostic Stewardship of Endotracheal Aspirate Cultures in a PICU.

Authors:  Anna C Sick-Samuels; Matthew Linz; Jules Bergmann; James C Fackler; Sean M Berenholtz; Shawn L Ralston; Katherine Hoops; Joe Dwyer; Elizabeth Colantuoni; Aaron M Milstone
Journal:  Pediatrics       Date:  2021-04-07       Impact factor: 7.124

3.  Trends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbation.

Authors:  Islem Ouanes; Lamia Ouanes-Besbes; Saoussen Ben Abdallah; Fahmi Dachraoui; Fekri Abroug
Journal:  Ann Intensive Care       Date:  2015-10-01       Impact factor: 6.925

4.  Building toolkits for COPD exacerbations: lessons from the past and present.

Authors:  Elizabeth Sapey; Mona Bafadhel; Charlotte Emma Bolton; Thomas Wilkinson; John R Hurst; Jennifer K Quint
Journal:  Thorax       Date:  2019-07-03       Impact factor: 9.139

Review 5.  [Triggering factors of acute COPD exacerbations].

Authors:  S Jouneau
Journal:  Rev Mal Respir       Date:  2017-05-02       Impact factor: 0.622

6.  COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD.

Authors:  Hendrik Johannes Prins; Ruud Duijkers; Johannes M A Daniels; Thys van der Molen; Tjip S van der Werf; Wim Boersma
Journal:  BMJ Open Respir Res       Date:  2021-02

7.  Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD.

Authors:  Nick A Francis; David Gillespie; Mandy Wootton; Patrick White; Janine Bates; Jennifer Richards; Hasse Melbye; Kerenza Hood; Christopher C Butler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-01

Review 8.  Methods of Sputum and Mucus Assessment for Muco-Obstructive Lung Diseases in 2022: Time to "Unplug" from Our Daily Routine!

Authors:  Jeremy Charriot; Mathilde Volpato; Aurélie Petit; Isabelle Vachier; Arnaud Bourdin
Journal:  Cells       Date:  2022-02-25       Impact factor: 6.600

9.  Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD.

Authors:  Ramon Boixeda; Pere Almagro; Jesús Díez-Manglano; Francisco Javier Cabrera; Jesús Recio; Isabel Martin-Garrido; Joan B Soriano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.